Volume 130, Issue 6, Pages (May 2006)

Slides:



Advertisements
Similar presentations
Overview and pathogenesis of celiac disease Martin F. Kagnoff Gastroenterology Volume 128, Issue 4, Pages S10-S18 (April 2005) DOI: /j.gastro
Advertisements

Christian F. Krieglstein, Christoph Anthoni, Wolfgang H
Volume 141, Issue 2, Pages e3 (August 2011)
Volume 131, Issue 4, Pages (October 2006)
Volume 141, Issue 6, Pages e7 (December 2011)
Our New President—Mark Donowitz, MD
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 127, Issue 1, Pages (July 2004)
Volume 136, Issue 1, Pages (January 2009)
Volume 135, Issue 2, Pages e3 (August 2008)
Volume 132, Issue 4, Pages (April 2007)
This month in Gastroenterology
Volume 141, Issue 2, Pages e3 (August 2011)
Volume 136, Issue 3, Pages (March 2009)
Volume 129, Issue 1, Pages (July 2005)
Volume 136, Issue 7, Pages e4 (June 2009)
Volume 131, Issue 4, Pages (October 2006)
Therapeutic potential of follistatin for colonic inflammation in mice
Volume 141, Issue 2, Pages e4 (August 2011)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 128, Issue 4, Pages (April 2005)
Volume 137, Issue 5, Pages e1 (November 2009)
Volume 154, Issue 5, Pages (April 2018)
Volume 144, Issue 5, Pages e6 (May 2013)
Volume 155, Issue 4, Pages (October 2018)
Galectin-1 suppresses experimental colitis in mice
Volume 134, Issue 1, Pages e1 (January 2008)
Volume 132, Issue 3, Pages (March 2007)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 130, Issue 6, Pages (May 2006)
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Volume 136, Issue 2, Pages (February 2009)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 130, Issue 2, Pages (February 2006)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 139, Issue 6, Pages (December 2010)
Volume 139, Issue 6, Pages (December 2010)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 140, Issue 4, Pages e2 (April 2011)
Severe Constipation Clinical Gastroenterology and Hepatology
Volume 138, Issue 4, Pages (April 2010)
This Month in Gastroenterology
Volume 134, Issue 7, Pages e3 (June 2008)
Volume 129, Issue 3, Pages (September 2005)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
Effects of IL-1α on the composition of infiltrating proinflammatory cells in inflamed colons during DSS-induced colitis. Effects of IL-1α on the composition.
The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice
Volume 19, Issue 13, Pages (June 2017)
Volume 119, Issue 4, Pages (October 2000)
A2B Adenosine Receptor Gene Deletion Attenuates Murine Colitis
Volume 135, Issue 2, Pages e2 (August 2008)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 132, Issue 3, Pages (March 2007)
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 132, Issue 5, Pages (May 2007)
Volume 141, Issue 3, Pages (September 2011)
Volume 41, Issue 4, Pages (October 2014)
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
Volume 132, Issue 2, Pages (February 2007)
Our New President—Mark Donowitz, MD
Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis  Jun Lu, Arthur Wang, Sara Ansari,
This month in Gastroenterology
Michelle Maria Pietzak  Gastroenterology 
Volume 140, Issue 4, Pages (April 2011)
Volume 125, Issue 3, Pages (September 2003)
Volume 136, Issue 7, Pages (June 2009)
Volume 128, Issue 1, Pages (January 2005)
This month in Gastroenterology
Presentation transcript:

Volume 130, Issue 6, Pages 1743-1753 (May 2006) Antidepressants Attenuate Increased Susceptibility to Colitis in a Murine Model of Depression  Ashwin K. Varghese, Elena F. Verdú, Premysl Bercik, Waliul I. Khan, Patricia A. Blennerhassett, Henry Szechtman, Stephen M. Collins  Gastroenterology  Volume 130, Issue 6, Pages 1743-1753 (May 2006) DOI: 10.1053/j.gastro.2006.02.007 Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 1 Immobility in MS adult mice before and after DMI treatment. Total time spent immobile is represented in seconds and was measured in mice on PND 60. MS mice were given DMI (MS-DMI; n = 8) or a saline vehicle (MS-saline; n = 4) on PND 23–36. US mice were given injections of saline vehicle (US-saline; n = 4). Data are means ± SEM. *P < .05 compared with US-saline mice; #P < .05 compared with MS-saline mice. Gastroenterology 2006 130, 1743-1753DOI: (10.1053/j.gastro.2006.02.007) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 2 Pattern of novelty-induced locomotor activity in adult MS and US mice. The distance traveled by mice per movement bout (mean length of locomotor bouts) is shown; arrow indicates that a novel object was introduced into the open field after the 10-minute mark. Data are means ± SEM (n = 18/group). •, Unseparated; ■, separated. Gastroenterology 2006 130, 1743-1753DOI: (10.1053/j.gastro.2006.02.007) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 3 Habituation of novelty-induced locomotor activity in adult MS and US mice. Change from the 0- to 10-minute interval to the 10- to 20-minute interval in (A) distance traveled and (B) locomotor duration. Data are means ± SEM (n = 18/group). *P < .05 compared with unseparated mice. Gastroenterology 2006 130, 1743-1753DOI: (10.1053/j.gastro.2006.02.007) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 4 Jejunal permeability to 51Cr-EDTA in adult MS and US mice. Fractions 1–4: luminal PBS; fractions 5–9: luminal 51Cr-EDTA; fractions 10–19: luminal PBS wash. (A) Recovery of γ radiation in each venous outflow fraction. *, Unseparated; ■, separated. (B) Total recovery of γ radiation for the duration of the experiment. Data are means ± SEM (n = 5/group). *P < .05 compared with US mice. Gastroenterology 2006 130, 1743-1753DOI: (10.1053/j.gastro.2006.02.007) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 5 Colitis severity in MS-DSS and US-DSS adult mice after DSS colitis induction. (A) The weight lost after DSS administration is presented as a percentage of the weight at PND 60. (B) Clinical disease score. Data are means ± SEM (n = 16/group). *P < .01 compared with US-DSS mice. Gastroenterology 2006 130, 1743-1753DOI: (10.1053/j.gastro.2006.02.007) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 6 Microscopic damage in MS and US adult mice after DSS colitis induction. (A) Microscopic damage. Data are means ± SEM (n = 16 mice/group). *P < .01 compared with US-DSS. (B) Representative histologic sections (200×) from both groups. Gastroenterology 2006 130, 1743-1753DOI: (10.1053/j.gastro.2006.02.007) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 7 Inflammation in MS and US adult mice after DSS colitis induction. (A) MPO activity in colonic tissue homogenates (n = 16/group). (B) IL-1β levels in colonic tissue (n = 12/group). (C) SAP levels (n = 16/group). Data are means ± SEM. *P < .01 compared with US-DSS mice. Gastroenterology 2006 130, 1743-1753DOI: (10.1053/j.gastro.2006.02.007) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 8 Colitis severity in MS mice treated with DMI after DSS colitis induction. (A) Clinical disease score. (B) Microscopic damage. (C) MPO activity in colonic tissue homogenates. Colitis was induced in MS-DMI and in MS-saline mice. Data are means ± SEM (n = 8/group). *P < .05 compared with MS-saline mice. Gastroenterology 2006 130, 1743-1753DOI: (10.1053/j.gastro.2006.02.007) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions